Universitat de Barcelona (UB) / University of Barcelona

Deep Frequency Re-calibration U-Net for Medical Image Segmentation (2021) Azad R, Bozorgpour A, Asadi-Aghbolaghi M, Merhof D, Escalera S Conference contribution Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. (2021) Eggermont AM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, et al. Journal article A Modified Progressive Supranuclear Palsy Rating Scale. (2021) Groetsch MT, Respondek G, Colosimo C, Compta Y, Corvol JC, Ferreira J, Huber MK, et al. Journal article Accelerated bioactive behavior of Nagelschmidtite bioceramics: Mimicking the nano and microstructural aspects of biological mineralization (2021) Rincón-López JA, Hermann-Muñoz JA, Cinca-Luis N, Fernández-Benavides DA, García-Cano I, Guilemany-Casadamon JM, Boccaccini AR, et al. Journal article Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice (2021) Dudding TC, Lehur PA, Sorensen M, Engelberg S, Bertapelle MP, Chartier-Kastler E, Everaert K, et al. Journal article, Review article Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial (2021) Stone JH, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, Rech J, et al. Journal article Olduvai's oldest Oldowan (2021) Stollhofen H, Stanistreet IG, Toth N, Schick KD, Rodriguez-Cintas A, Albert RM, Farrugia P, et al. Journal article, Original article The global impact of the COVID-19 pandemic on the management and course of chronic urticaria (2020) Kocaturk E, Salman A, Cherrez-Ojeda I, Criado PR, Peter J, Comert-Ozer E, Abuzakouk M, et al. Journal article Palaeovegetation changes recorded in Palaeolake Olduvai OGCP Core 2A (2.09–2.12 Ma) Naibor Soit Formation Olduvai Gorge, Tanzania (2020) Rodríguez-Cintas A, Albert RM, Bamford MK, Stanistreet IG, Stollhofen H, Stone JR, Rivera-Rondón C, et al. Journal article, Original article EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) plus nab-paclitaxel (nabPTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation (2020) Sharma P, Farooki A, Fasching P, Loi S, Peterson K, Prat A, Tripathy D, et al. Conference contribution